Oxford Biomedica (OXB) News Today GBX 299 -5.00 (-1.64%) As of 04/17/2025 11:56 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Oxford Biomedica (LON:OXB) Shares Up 12.1% - Here's What HappenedOxford Biomedica (LON:OXB) Shares Up 12.1% - Here's WhyApril 12, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Posts Quarterly Earnings ResultsOxford Biomedica (LON:OXB - Get Free Report) announced its quarterly earnings data on Wednesday. The biopharmaceutical company reported GBX (41.75) (($0.53)) earnings per share for the quarter. Oxford Biomedica had a negative return on equity of 202.50% and a negative net margin of 145.98%.April 11, 2025 | marketbeat.comOxford Biomedica reports FY24 EPS (GPB 41.75) vs. (GPB 163.11) last yearApril 10, 2025 | msn.comOxford Biomedica falls on lower EBITDA outlook despite strong revenue guideApril 9, 2025 | investing.comViroCell Biologics Appoints Viral Vector Expert as Special AdvisorMarch 28, 2025 | finance.yahoo.comOXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' categoryMarch 21, 2025 | markets.businessinsider.comOxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average - Here's WhyOxford Biomedica (LON:OXB) Stock Crosses Below 200 Day Moving Average - Time to Sell?March 11, 2025 | marketbeat.comOxford Biomedica backs novel cystic fibrosis gene therapy trialFebruary 22, 2025 | investing.comBoehringer and partners commence gene therapy trial for cystic fibrosisFebruary 21, 2025 | msn.comBoehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosisFebruary 20, 2025 | markets.businessinsider.comNovel inhalable gene therapy trialed for people with cystic fibrosisFebruary 20, 2025 | msn.comSMALL-CAP WINNERS & LOSERS: Wilmington half-year profit fallsFebruary 17, 2025 | lse.co.ukOxford BioMedica shares fall as revenue to stay below 2022 levelFebruary 17, 2025 | lse.co.ukOxford Biomedica Share Chat (OXB)February 15, 2025 | lse.co.ukOxford Biomedica (LON:OXB) Stock Passes Above 200-Day Moving Average - Should You Sell?Oxford Biomedica (LON:OXB) Stock Passes Above 200 Day Moving Average - Should You Sell?February 13, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Share Price Crosses Above 200-Day Moving Average - Here's WhyOxford Biomedica (LON:OXB) Stock Price Crosses Above 200 Day Moving Average - Here's WhyFebruary 5, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Reaches New 52-Week High - Time to Buy?Oxford Biomedica (LON:OXB) Reaches New 1-Year High - Here's WhyJanuary 28, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Crosses Above Fifty Day Moving Average - Should You Sell?Oxford Biomedica (LON:OXB) Share Price Crosses Above 50-Day Moving Average - Here's What HappenedJanuary 7, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Share Price Crosses Above Fifty Day Moving Average - What's Next?Oxford Biomedica (LON:OXB) Stock Price Crosses Above 50-Day Moving Average - Here's WhyDecember 28, 2024 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Up 0.1% - Here's What HappenedOxford Biomedica (LON:OXB) Trading 0.1% Higher - Should You Buy?December 12, 2024 | marketbeat.comOxford Biomedica Strengthens Board with Key AppointmentNovember 18, 2024 | msn.comOxford Biomedica (LON:OXB) Shares Cross Above 200-Day Moving Average - Should You Sell?Oxford Biomedica (LON:OXB) Share Price Passes Above 200 Day Moving Average - Time to Sell?November 2, 2024 | marketbeat.comOxford Biomedica Announces Total Voting Rights UpdateNovember 1, 2024 | markets.businessinsider.comOxford BioMedica Sees Shift in Voting RightsOctober 31, 2024 | markets.businessinsider.comOxford Biomedica (LON:OXB) Hits New 1-Year High - Should You Buy?Oxford Biomedica (LON:OXB) Sets New 12-Month High - Should You Buy?October 25, 2024 | marketbeat.comThis skyrocketing growth stock is up 100% this year! Is it too late to buy?October 23, 2024 | msn.comOxford Biomedica (LON:OXB) Sets New 52-Week High - Still a Buy?Oxford Biomedica (LON:OXB) Hits New 52-Week High - Here's WhyOctober 16, 2024 | marketbeat.comOxford BioMedica PLC (OXBDF) (Q2 2024) Earnings Call Transcript Highlights: Strong Revenue ...September 24, 2024 | finance.yahoo.comOxford Biomedica plc (OXBDF) Q2 2024 Earnings Call TranscriptSeptember 23, 2024 | seekingalpha.comPositive Signs As Multiple Insiders Buy Oxford Biomedica StockSeptember 16, 2024 | finance.yahoo.comOxford Biomedica to host a free webinar showcasing its AAV expertiseAugust 27, 2024 | uk.finance.yahoo.comOxford Biomedica Regulatory NewsAugust 13, 2024 | lse.co.ukOxford BioMedica plc: Oxford Biomedica - Half Year Trading Update and Notice of Interim ResultsAugust 8, 2024 | finanznachrichten.deOxford BioMedica plc: Oxford Biomedica announces CFO transitionJuly 19, 2024 | finanznachrichten.deOxford Biomedica (LON:OXB) investors are sitting on a loss of 71% if they invested three years agoMay 28, 2024 | finance.yahoo.comOxford Biomedica (LON:OXB) investors are sitting on a loss of 71% if they invested three years agoMay 28, 2024 | finance.yahoo.comOxford Biomedica Share ChatMay 23, 2024 | lse.co.ukOxford Biomedica (LON:OXB) Given Outperform Rating at Royal Bank of CanadaRoyal Bank of Canada restated an "outperform" rating and set a GBX 740 ($9.41) price target on shares of Oxford Biomedica in a report on Tuesday.May 21, 2024 | marketbeat.comOxford BioMedica plc: Update to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary ResultsMarch 5, 2024 | finanznachrichten.deUpdate to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary ResultsMarch 5, 2024 | finance.yahoo.comOxford Biomedica (LON:OXB) Share Price Crosses Below Two Hundred Day Moving Average of $251.96Oxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average of $251.96February 10, 2024 | marketbeat.comEnSilica hires new chief financial officer from Oxford BiomedicaFebruary 5, 2024 | lse.co.ukOxford Biomedica (LON:OXB) Shares Pass Below Two Hundred Day Moving Average of $263.21Oxford Biomedica (LON:OXB) Stock Price Crosses Below 200 Day Moving Average of $263.21February 2, 2024 | marketbeat.comOxford Biomedica completes acquisition of ABL EuropeJanuary 29, 2024 | finance.yahoo.comOxford Biomedica (LON:OXB) shareholders have endured a 79% loss from investing in the stock three years agoDecember 19, 2023 | finance.yahoo.comOxford Biomedica inks deal to provide ‘footprint’ in EU marketDecember 4, 2023 | msn.comOxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position as a global pure-play CDMODecember 4, 2023 | finance.yahoo.comOxford Biomedica's UK£39m Market Cap Fall Books Insider LossesOctober 22, 2023 | finance.yahoo.comOxford Biomedica First Half 2023 Earnings: Misses ExpectationsSeptember 22, 2023 | finance.yahoo.comOxford BioMedica shares soar as vaccine maker raises earnings guidanceSeptember 20, 2023 | finance.yahoo.com Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Email Address OXB Media Mentions By Week OXB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXB News Sentiment▼0.060.49▲Average Medical News Sentiment OXB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXB Articles This Week▼10▲OXB Articles Average Week Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Oxford Nanopore Technologies News PureTech Health News Faron Pharmaceuticals Oy News 4basebio News Avacta Group News Bioventix News hVIVO News Scancell News Ondine Biomedical News e-therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OXB) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OXB Stock Free OXB Stock Alerts